Comparative Effects of Aspirin and NHP-544C

计划入组 61 人 · 首次发布于 2014 年 7 月 14 日

Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®

计划入组 100 人 · 首次发布于 2025 年 3 月 14 日

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

计划入组 12 人 · 首次发布于 2007 年 11 月 26 日

NHP-07

NHP-229 (Yale University)

X-Synergy®

C & C Oxygen Company

United States

Buchanan C Michael

United States

DENVER NEPHROLOGISTS P C

United States

Ncardia Launches First Commercial iPSC-Derived Non-Human Primate Cardiomyocytes for Cardiac Safety Testing

HkeyBio Launches NHP Fast-PoC Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices

Beam Therapeutics' ESCAPE Platform Shows Promise in Non-Genotoxic Conditioning for Sickle Cell Disease